CD274 and neoplasm: Both papers suggest that PD-L1 expression on tumor cells is not essential for an efficient response to anti-PD-L1 therapy, and this could explain why also some patients negative for PD-L1 in the tumor respond to PD-L1/PD-1 blockade.